Eileen Friedman

3.9k total citations
75 papers, 3.2k citations indexed

About

Eileen Friedman is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Eileen Friedman has authored 75 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 39 papers in Oncology and 19 papers in Pathology and Forensic Medicine. Recurrent topics in Eileen Friedman's work include Cancer-related Molecular Pathways (17 papers), Genetic factors in colorectal cancer (14 papers) and Colorectal Cancer Treatments and Studies (11 papers). Eileen Friedman is often cited by papers focused on Cancer-related Molecular Pathways (17 papers), Genetic factors in colorectal cancer (14 papers) and Colorectal Cancer Treatments and Studies (11 papers). Eileen Friedman collaborates with scholars based in United States, France and Belgium. Eileen Friedman's co-authors include Daina Z. Ewton, Xiaobing Deng, Stephen E. Mercer, Sidney J. Winawer, Zhongfa Yan, Kideok Jin, Seunghwan Lim, Hamilton O. Smith, Martin Lipkin and Carl L. Schildkraut and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Eileen Friedman

74 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eileen Friedman United States 36 2.1k 1.1k 378 358 334 75 3.2k
Emma Shtivelman United States 33 2.4k 1.1× 931 0.8× 399 1.1× 602 1.7× 331 1.0× 42 4.2k
Hiroya Asou Japan 29 2.3k 1.1× 1.2k 1.1× 535 1.4× 839 2.3× 195 0.6× 70 3.9k
Fausto Grignani Italy 20 3.0k 1.4× 677 0.6× 237 0.6× 229 0.6× 158 0.5× 50 3.8k
Mohamed Rahmani United States 47 3.9k 1.9× 1.4k 1.2× 429 1.1× 554 1.5× 177 0.5× 95 5.7k
Giovanna Tabellini Italy 37 2.2k 1.1× 882 0.8× 188 0.5× 346 1.0× 259 0.8× 74 3.9k
Teresa A. Lehman United States 25 1.4k 0.6× 1.1k 1.0× 350 0.9× 500 1.4× 92 0.3× 47 2.8k
Cécile Demur France 29 2.0k 0.9× 1.0k 0.9× 157 0.4× 352 1.0× 214 0.6× 79 3.4k
David J. Mulholland United States 28 2.9k 1.4× 1.2k 1.0× 230 0.6× 937 2.6× 233 0.7× 50 4.4k
Luigi Pegoraro Italy 31 1.7k 0.8× 724 0.6× 161 0.4× 354 1.0× 208 0.6× 108 3.5k
Rui‐An Wang United States 29 2.2k 1.1× 1.1k 1.0× 191 0.5× 604 1.7× 114 0.3× 56 3.1k

Countries citing papers authored by Eileen Friedman

Since Specialization
Citations

This map shows the geographic impact of Eileen Friedman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eileen Friedman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eileen Friedman more than expected).

Fields of papers citing papers by Eileen Friedman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eileen Friedman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eileen Friedman. The network helps show where Eileen Friedman may publish in the future.

Co-authorship network of co-authors of Eileen Friedman

This figure shows the co-authorship network connecting the top 25 collaborators of Eileen Friedman. A scholar is included among the top collaborators of Eileen Friedman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eileen Friedman. Eileen Friedman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deng, Xiaobing, Jing Hu, Daina Z. Ewton, & Eileen Friedman. (2014). Mirk/dyrk1B kinase is upregulated following inhibition of mTOR. Carcinogenesis. 35(9). 1968–1976. 25 indexed citations
2.
Friedman, Eileen. (2013). Mirk/dyrk1B Kinase in Ovarian Cancer. International Journal of Molecular Sciences. 14(3). 5560–5575. 29 indexed citations
3.
Hu, Jing, et al.. (2012). Ovarian cancer cells, not normal cells, are damaged by Mirk/Dyrk1B kinase inhibition. International Journal of Cancer. 132(10). 2258–2269. 35 indexed citations
4.
Ewton, Daina Z., Jing Hu, Maria Vilenchik, et al.. (2011). Inactivation of Mirk/Dyrk1b Kinase Targets Quiescent Pancreatic Cancer Cells. Molecular Cancer Therapeutics. 10(11). 2104–2114. 56 indexed citations
5.
6.
Deng, Xiaobing, Daina Z. Ewton, & Eileen Friedman. (2009). Mirk/Dyrk1B Maintains the Viability of Quiescent Pancreatic Cancer Cells by Reducing Levels of Reactive Oxygen Species. Cancer Research. 69(8). 3317–3324. 80 indexed citations
7.
Mercer, Stephen E. & Eileen Friedman. (2006). Mirk/Dyrk1B: A Multifunctional Dual-Specificity Kinase Involved in Growth Arrest, Differentiation, and Cell Survival. Cell Biochemistry and Biophysics. 45(3). 303–315. 52 indexed citations
8.
Mercer, Stephen E., et al.. (2006). Mirk/Dyrk1b Mediates Cell Survival in Rhabdomyosarcomas. Cancer Research. 66(10). 5143–5150. 45 indexed citations
9.
Deng, Xiaobing, Daina Z. Ewton, Stephen E. Mercer, & Eileen Friedman. (2004). Mirk/dyrk1B Decreases the Nuclear Accumulation of Class II Histone Deacetylases during Skeletal Muscle Differentiation. Journal of Biological Chemistry. 280(6). 4894–4905. 61 indexed citations
10.
Lim, Seunghwan, Yonglong Zou, & Eileen Friedman. (2002). The Transcriptional Activator Mirk/Dyrk1B Is Sequestered by p38α/β MAP Kinase. Journal of Biological Chemistry. 277(51). 49438–49445. 25 indexed citations
11.
Ewton, Daina Z., Sanjay Kansra, Seunghwan Lim, & Eileen Friedman. (2002). Insulin‐like growth factor‐I has a biphasic effect on colon carcinoma cells through transient inactivation of forkhead1, initially mitogenic, then mediating growth arrest and differentiation. International Journal of Cancer. 98(5). 665–673. 23 indexed citations
12.
Huang, Fei, et al.. (1995). Colon Absorptive Epithelial Cells Lose Proliferative Response to TGFα as They Differentiate. Experimental Cell Research. 219(1). 8–14. 23 indexed citations
13.
Hsu, Stephen, Fei Huang, Mohamed M. Hafez, Sidney J. Winawer, & Eileen Friedman. (1994). Colon carcinoma cells switch their response to transforming growth factor beta 1 with tumor progression.. PubMed. 5(3). 267–75. 74 indexed citations
14.
Huang, Fei, Stephen Hsu, Zhongfa Yan, S. J. Winawer, & Eileen Friedman. (1994). The capacity for growth stimulation by TGF beta 1 seen only in advanced colon cancers cannot be ascribed to mutations in APC, DCC, p53 or ras.. PubMed. 9(12). 3701–6. 25 indexed citations
15.
Schroy, Paul C., Alfred Cohen, Sidney J. Winawer, & Eileen Friedman. (1990). Effects of FUdR on primary‐cultured colon carcinomas metastatic to the liver. Journal of Surgical Oncology. 45(4). 217–223. 4 indexed citations
16.
Friedman, Eileen, et al.. (1989). Fecal diglycerides as selective endogenous mitogens for premalignant and malignant human colonic epithelial cells.. PubMed. 49(3). 544–8. 74 indexed citations
17.
Schroy, Paul C., et al.. (1988). Heterogeneous responses of human colon carcinomas to hexamethylene bisacetamide.. PubMed. 48(19). 5487–94. 16 indexed citations
18.
Buset, Michel, Martin Lipkin, Sidney J. Winawer, Shanti Swaroop, & Eileen Friedman. (1986). Inhibition of human colonic epithelial cell proliferation in vivo and in vitro by calcium.. PubMed. 46(10). 5426–30. 153 indexed citations
19.
Higgins, Paul J., Eileen Friedman, Martin Lipkin, et al.. (1983). Expression of Gastric-Associated Antigens by Human Premalignant and Malignant Colonic Epithelial Cells. Oncology. 40(1). 26–30. 6 indexed citations
20.
Friedman, Eileen & Hamilton O. Smith. (1973). Production of Possible Recombination Intermediates by an ATP-dependent DNAase. Nature New Biology. 241(106). 54–58. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emma Shtivelman Breakdown of academic impact, for papers by Hiroya Asou Breakdown of academic impact, for papers by Fausto Grignani Breakdown of academic impact, for papers by Mohamed Rahmani Breakdown of academic impact, for papers by Giovanna Tabellini Breakdown of academic impact, for papers by Teresa A. Lehman Breakdown of academic impact, for papers by Cécile Demur Breakdown of academic impact, for papers by David J. Mulholland Breakdown of academic impact, for papers by Luigi Pegoraro Breakdown of academic impact, for papers by Rui‐An Wang
Rankless by CCL
2026